NT PHARMA: 2026 Interim Report

HKEXSep 29 16:37

Tailing Pharmaceutical Ordered to Pay RMB 75 Million in Arbitration; Applies to Set Aside Award

Tailong Pharmaceutical (01011.HK) announced that on the 22nd, it received an award from the China International Economic and Trade Arbitration Commission in its second arbitration case. According to

AASTOCKSSep 28 09:42

China NT Pharma Completes Loan Capitalisation Via Major Share Subscription

TipRanksSep 4 19:07

Tailin Pharmaceutical (01011): Wang Zhiqiang appointed as Company Secretary, Authorized Representative, and Agent for Service of Process

Tailin Pharmaceutical (01011) announced that Ms. Li Yifang has resigned as the company secretary, authorized representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, and agent for service of process in Hong Kong under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), effective August 31, 2026. Mr. Wang Zhiqiang has been appointed as the company secretary, authorized representative, and agent for service of process, effective August 31, 2026.

Zhitong FinanceAug 31 21:26

Tai Ling Pharmaceutical (01011) recorded a total market value of HK$22.4408 million in share transfers, accounting for 5.91% of the volume, with 56 million shares transferred out from New Yongan International Securities.

On August 28, Tailin Pharmaceutical (01011) experienced unusual position activity, with a total transferred market value of HK$22.4408 million, accounting for 5.91%.

Zhitong FinanceAug 31 08:59

China NT Pharma Wins Share Issue Mandate but Loses Auditor Vote at EGM

TipRanksAug 28 23:14